12:00 AM
 | 
Jun 17, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Access Pharmaceuticals, AMAG Pharmaceuticals sales and marketing update

AMAG licensed exclusive, U.S. commercialization rights to MuGard mucoadhesive oral rinse from Access for an upfront payment of $3.3 million. Access is...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >